Validation of abnormal glucose metabolism associated with Parkinson’s disease in Chinese participants based on 18F-fluorodeoxyglucose positron emission tomography imaging
Rongbing Jin,1,* Jingjie Ge,2,* Ping Wu,2 Jiaying Lu,2 Huiwei Zhang,2 Jian Wang,3 Jianjun Wu,3 Xianhua Han,2 Weishan Zhang,2 Chuantao Zuo2,4 1Department of Nuclear Medicine, Daping Hospital, Army Medical University, Chongqing 400042, China; 2PET Center, Huashan Hospital, Fudan University, Shanghai...
Guardado en:
Autores principales: | Jin R, Ge J, Wu P, Lu J, Zhang H, Wang J, Wu J, Han X, Zhang W, Zuo C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/de67a45d3d384432aa76423d573fe29a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The role of positron emission tomography in different types of malignant lymphomas: the results of 2020
por: Vladislav O. Sarzhevskiy, et al.
Publicado: (2021) -
VMAT2 availability in Parkinson’s disease with probable REM sleep behaviour disorder
por: Mikaeel Valli, et al.
Publicado: (2021) -
Transfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review
por: Deevyankar Agarwal, et al.
Publicado: (2021) -
18F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies
por: Michinori Ezura, et al.
Publicado: (2021) -
Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography
por: Sawada S, et al.
Publicado: (2016)